Adjuvant chemotherapy with 5-FU or regimens including oral fluoropyrimidine for curable gastric cancer

被引：2

作者：

Sasako, Mitsuru ^{[1
]}

机构：

[1] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan

来源：

GASTRIC CANCER | 2009年 / 12卷

关键词：

Adjuvant treatment; Fluorouracil; Chemoradiotherapy; Gastric cancer; RANDOMIZED-TRIAL; CURATIVE RESECTION; SURGERY; STOMACH; JAPAN; CHEMORADIOTHERAPY; ADENOCARCINOMA; 5-FLUOROURACIL; FLUOROURACIL; MITOMYCIN;

D O I：

10.1007/s10120-008-0465-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Since 2000, several studies have reported positive results in reasonable-size randomized controlled trials of adjuvant treatment for potentially curable gastric cancer. At present, postoperative adjuvant chemoradiotherapy and perioperative chemotherapy are the standard of care in the United States and Europe (including Great Britain), respectively, while postoperative S-1 monotherapy is the standard of care in Japan. The effect of adjuvant treatment varies according to the type of surgery, and the best results so far have been observed in the adjuvant chemotherapy of TS-1 for gastric cancer (ACTS-GC) trial, in which D2 surgery followed by S-1 monotherapy was tested. The role of radiotherapy after D2 dissection remains unclear.

引用

页码：10 / 15

页数：6

共 22 条

[1] Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group [J].

Bajetta, E ;

Buzzoni, R ;

Mariani, L ;

Beretta, E ;

Bozzetti, F ;

Bordogna, G ;

Aitini, E ;

Fava, S ;

Schieppati, G ;

Pinotti, G ;

Visini, M ;

Ianniello, G ;

Di Bartolomeo, M .

ANNALS OF ONCOLOGY, 2002, 13 (02) :299-307

[2] COMPARISON OF FACTORS INFLUENCING THE PROGNOSIS OF JAPANESE, GERMAN, AND DUTCH GASTRIC-CANCER PATIENTS [J].

BONENKAMP, JJ ;

VANDEVELDE, CJH ;

KAMPSCHOER, GHM ;

HERMANS, J ;

HERMANEK, P ;

BEMELMANS, M ;

GOUMA, DJ ;

SASAKO, M ;

MARUYAMA, K .

WORLD JOURNAL OF SURGERY, 1993, 17 (03) :410-415

[3] Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer:: 7-year results of the FFCD randomized phase III trial (8801) [J].

Bouché, O ;

Ychou, M ;

Burtin, P ;

Bedenne, L ;

Ducreux, M ;

Lebreton, G ;

Baulieux, J ;

Nordlinger, B ;

Martin, C ;

Seitz, JF ;

Tigaud, JM ;

Echinard, E ;

Stremsdoerfer, N ;

Milan, C ;

Rougier, P .

ANNALS OF ONCOLOGY, 2005, 16 (09) :1488-1497

[4] SURGICAL PATHOLOGICAL-STAGE MIGRATION CONFOUNDS COMPARISONS OF GASTRIC-CANCER SURVIVAL RATES BETWEEN JAPAN AND WESTERN COUNTRIES [J].

BUNT, AMG ;

HERMANS, J ;

SMIT, VTHBM ;

VANDEVELDE, CJH ;

FLEUREN, GJ ;

BRUIJN, JA .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :19-25

[5] Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer [J].

Chipponi, J ;

Huguier, M ;

Pezet, D ;

Basso, N ;

Hay, JM ;

Quandalle, P ;

Jaeck, D ;

Fagniez, PL ;

Gainant, A .

AMERICAN JOURNAL OF SURGERY, 2004, 187 (03) :440-445

[6] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].

Cunningham, David ;

Allum, William H. ;

Stenning, Sally P. ;

Thompson, Jeremy N. ;

Van de Velde, Cornelis J. H. ;

Nicolson, Marianne ;

Scarffe, J. Howard ;

Lofts, Fiona J. ;

Falk, Stephen J. ;

Iveson, Timothy J. ;

Smith, David B. ;

Langley, Ruth E. ;

Verma, Monica ;

Weeden, Simon ;

Chua, Yu Jo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20

[7] Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) [J].

De Vita, F. ;

Giuliani, F. ;

Orditura, M. ;

Maiello, E. ;

Galizia, G. ;

Di Martino, N. ;

Montemurro, F. ;

Carteni, G. ;

Manzione, L. ;

Romito, S. ;

Gebbia, V. ;

Ciardiello, F. ;

Catalano, G. ;

Colucci, G. .

ANNALS OF ONCOLOGY, 2007, 18 (08) :1354-1358

[8] Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment [J].

Hundahl, SA ;

Macdonald, JS ;

Benedetti, J ;

Fitzsimmons, T .

ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (03) :278-286

[9] An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach [J].

Kim, S ;

Lim, DH ;

Lee, J ;

Kang, WK ;

MacDonald, JS ;

Park, CH ;

Park, SH ;

Lee, SH ;

Kim, K ;

Park, JO ;

Kim, WS ;

Jung, CW ;

Park, YS ;

Im, YH ;

Sohn, TS ;

Noh, JH ;

Heo, JS ;

Kim, YI ;

Park, CK ;

Park, K .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (05) :1279-1285

[10] Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. [J].

Macdonald, JS ;

Smalley, SR ;

Benedetti, J ;

Hundahl, SA ;

Estes, NC ;

Stemmermann, GN ;

Haller, DG ;

Ajani, JA ;

Gunderson, LL ;

Jessup, JM ;

Martenson, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (10) :725-730

← 1 2 3 →